KMT2A and acute myeloid leukemia: Consistently with the results obtained in APL, in the murine MLL-AF9/NRASG12D and MLL-ENL AML models, PVT1 depletion activated a myeloid differentiation program, with downregulation of cKit and leukemia stem cell signatures and upregulation of CD11b [44].